Treatment of Malignant Endocrine Pancreatic Tumors with a Combination of α-Interferon and Somatostatin Analogs
- 1 January 2002
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 19 (1), 35-42
- https://doi.org/10.1385/mo:19:1:35
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Combination Therapy With Octreotide and α-Interferon:American Journal of Gastroenterology, 1999
- Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.1992
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumorsCancer, 1990
- Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumorsDigestive Diseases and Sciences, 1989
- Islet Cell Tumors Metastatic to the Liver: Effective Palliation by Sequential Hepatic Artery EmbolizationAnnals of Internal Medicine, 1988
- TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERONThe Lancet, 1986
- Apudomas metastatic to the liver: treatment by hepatic artery embolization.Radiology, 1983
- Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1980
- Effect of Long‐Term Treatment with Human Leukocyte Interferon on Various Laboratory ParametersActa Medica Scandinavica, 1980